Two DOSimetry TELescopes (DOSTELs) have been measuring the radiation environment in the Columbus module of the International Space Station (ISS) since 2009 in the frame of the DOSIS and DOSIS 3D projects. Both instruments have measured the charged particle flux rate and dose rates in a telescope geometry of two planar silicon detectors. The radiation environment in the ISS orbit is mostly composed by galactic cosmic radiation (GCR) and its secondary radiation and protons from the inner radiation belt in the South Atlantic Anomaly (SAA) with sporadic contributions of solar energetic particles at high latitudes. The data presented in this work cover two solar activity minima and corresponding GCR intensity maxima in 2009 and 2020 and the solar activity maximum and corresponding GCR intensity minimum in 2014/2015. Average dose rates measured in the Columbus laboratory in the ISS orbit from GCR and SAA are presented separately. The data is analyzed with respect to the effective magnetic shielding and grouped into different cut-off rigidity intervals. Using only measurements in magnetically unshielded regions at low cut-off rigidity and applying a factor for the geometrical shielding of the Earth, absorbed dose rates and dose equivalent rates in near-Earth interplanetary space are estimated for the years 2009 to 2022.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lssr.2023.04.002DOI Listing

Publication Analysis

Top Keywords

dose rates
12
columbus laboratory
8
international space
8
space station
8
radiation environment
8
iss orbit
8
solar activity
8
corresponding gcr
8
gcr intensity
8
cut-off rigidity
8

Similar Publications

Anti-inflammatory, immunostimulant and antimicrobial properties of tannic acid in the diet of Oreochromis niloticus infected with Aeromonas hydrophila.

Fish Shellfish Immunol

January 2025

Aquatic Organisms Health Laboratory (AQUOS), Aquaculture Department, UFSC, Rodovia Admar Gonzaga 1346, 88037-000 Florianópolis, SC, Brazil. Electronic address:

The study aimed to assess the impact of dietary supplementation with tannic acid on the growth, health, and survival of Oreochromis niloticus following exposure to Aeromonas hydrophila. A total of 320 fish were divided into 16 tanks and assigned to four treatment groups: feed with 0.2% tannic acid (TA), 0.

View Article and Find Full Text PDF

Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®.

Vaccine

January 2025

Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Introduction: While it remains impossible to predict the timing of the next influenza pandemic, novel avian influenza A viruses continue to be considered a significant threat.

Methods: A Phase II study was conducted in healthy adults aged 18-64 years to assess the safety and immunogenicity of two intramuscular doses of pre-pandemic 2017 influenza A(H7N9) inactivated vaccine administered 21 days apart. Participants were randomized (n = 105 in each of Arms 1-3) to receive 3.

View Article and Find Full Text PDF

Introduction: Droperidol is a dopamine-2 receptor antagonist in the class of butyrophenone antipsychotics with antiemetic, sedative, analgesic, and anxiolytic properties. In the postoperative setting, droperidol provides an opioid sparing effect and decreases nausea/vomiting. Another butyrophenone antipsychotic, haloperidol, has been shown to reduce morphine milliequivalents (MME) administered when used for abdominal pain in the emergency department (ED).

View Article and Find Full Text PDF

Objectives: Bimekizumab, a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)‑17F in addition to IL-17A, previously demonstrated efficacy and was well tolerated to 1 year in patients with non-radiographic (nr-) and radiographic (r-) axial spondyloarthritis (axSpA). Here, we report bimekizumab safety and efficacy to 2 years.

Methods: Patients completing week 52 in the phase 3 studies BE MOBILE 1 (nr-axSpA; NCT03928704) and 2 (r‑axSpA; NCT03928743) were eligible for an ongoing open‑label extension (OLE; NCT04436640).

View Article and Find Full Text PDF

Background: Implementation of semaglutide weight loss therapy has been challenging due to drug supply and cost, underscoring a need to identify those who derive the greatest absolute benefit.

Objectives: Allocation of semaglutide was modeled according to coronary artery calcium (CAC) among individuals without diabetes or established atherosclerotic cardiovascular disease (CVD).

Methods: In this analysis, 3,129 participants in the MESA (Multi-Ethnic Study of Atherosclerosis) without diabetes or clinical CVD met body mass index criteria for semaglutide and underwent CAC scoring on noncontrast cardiac computed tomography.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!